Columbia Engineering researchers have introduced a novel approach for creating bioactive injectable hydrogels containing extracellular vesicles (EVs) sourced from milk, with the aim of advancing applications in tissue engineering and regenerative medicine. These findings, recently published in Matter, showcase a groundbreaking hydrogel platform that utilizes EVs to address challenges in biomaterial development for regenerative purposes. Extracellular vesicles are natural particles released by cells, carrying a myriad of biological signals that facilitate intricate cellular communication, a feat that synthetic materials struggle to replicate effectively.
In this study led by Santiago Correa and his team, the unique hydrogel system incorporates EVs as both bioactive cargo and essential structural components, achieved by crosslinking biocompatible polymers with milk EVs sourced from yogurt. By leveraging yogurt EVs, the researchers overcame limitations in yield that typically impede the progress of EV-based biomaterials. The resulting hydrogel not only mimics the mechanical properties of living tissues but also actively engages neighboring cells, thereby promoting tissue healing and regeneration without the need for additional chemical additives.
The interdisciplinary collaboration between Correa’s Nanoscale Immunoengineering Lab at Columbia University and international partners from the University of Padova proved instrumental in demonstrating the versatility and potential of this innovative approach. By utilizing yogurt-derived EVs as a key design element, the team has laid the foundation for developing hydrogels that can merge both structural and biological functionalities. Moreover, early studies in mice have shown promising results, indicating potent angiogenic activity and the creation of an immune environment conducive to tissue repair.
The utilization of yogurt EV hydrogels showcases remarkable biocompatibility and therapeutic potential, offering a glimpse into the future of regenerative medicine where materials can closely mimic the natural environment of the body to accelerate healing processes. This breakthrough not only highlights the significance of agricultural EVs in biomaterial research but also underscores the promising role they may play in next-generation biotechnologies. By integrating EVs into the hydrogel structure, sustained delivery of bioactive signals becomes possible, paving the way for enhanced wound healing and tissue regeneration therapies.
Key Takeaways:
– Columbia engineers have developed a unique hydrogel system using yogurt-derived extracellular vesicles for tissue regeneration applications.
– The hydrogel mimics living tissue mechanics and promotes tissue healing without the need for additional chemical additives.
– Through international collaboration, the team has demonstrated the versatility of the hydrogel platform across diverse vesicle sources for regenerative medicine.
– Early experiments in mice have shown the hydrogel’s biocompatibility and its ability to promote angiogenic activity and create an immune environment conducive to tissue repair.
Tags: tissue engineering, drug delivery, regenerative medicine
Read more on sciencedaily.com